Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

An Open Label Safety and Exploratory Efficacy Study of Kanglaite Injection in Patients Having Progressive Stage IV NSCLC Who Are Not Candidates for Other Anti-cancer Treatment

This study is for patients with advanced non small cell lung cancer that has progressed despite standard of care. The purpose of the study is to see if Kanglaite injection has any effect on survival.

Inclusion Criteria:

• confirmed (within last 3 months)progressive Stage IV NSCLC
• estimated life span of 3 months
• phase angle of at least 5 as measured by bioimpedance

Exclusion Criteria:

• currently taking a lipid lowering medications
• has an imminently life threatening condition
• has pre-existing liver disease
• known allergy to soybeans
• uncontrolled diabetes or uncontrolled disturbance of lipid metabolism
• pregnant or lactating
• has a pacemaker or other implantable electronic medical device